Gastrointestinal drugs market to hit $48.4 bn dollars by 2022
Approval of new drugs, as well as rising prevalence, are expected to drive considerable growth
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Major depressive disorder market will reach $5.8 bn by 2025 as awareness and drugs improve
The market will be primarily driven by the growth of atypical antipsychotics, along with the increasing global diagnosed…
Raising Standards
After a few falls starts and delays, India's pharmacopeia is finally being updated and harmonised with global norms. By Sachin…
Pharma brands must think first about patients’ lives, then how their products can improve…
Brian Fox, as global leader, Marketing & Sales practice, Pharmaceuticals & Medical Products, McKinsey & Company, as…
‘Our next vaccine will be a three-dose rabies vaccine based on nano-particle technology’
Dr Rajiv Modi, CMD, CPL Biologicals, elaborates on the vaccines developed by his company, the huge positive impact they can have…
CPhI & P-MEC India to be held in Mumbai
UBM India set to celebrate 10 years of success with one week of glory
CubeX to host conference on consumer healthcare in Mumbai
It would cover diverse topics such as building mega brands to penetrating unchartered territories, creating multiple touch points…
68th IPCE to be held in Hyderabad
Delegates from across the world will congregate in Visakhapatnam from December 16 to 18, 2016
Pharmasafe India successfully concludes its second edition
The conference brought together 102 attendees along with 25 eminent speakers to focus on the strategies and identify solutions to…
7th PHARMAC INDIA, Pharmaceutical Ancillary Expo held in Ahmedabad
The main highlight for this year’s event was participation from China